National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

[18F]-ML-10
A small molecular-weight, malonic acid-based probe [(2-(5-fluoro-pentyl)-2-methyl-malonic acid or ML-10] labeled with the radioactive isotope fluorine F 18 with potential apoptosis radioimaging use. Upon administration, [F18]-ML-10 binds selectively to apoptotic cells due to apoptotic cell membrane features that differ from those of normal, healthy and necrotic cell membranes. Upon entering the apoptotic cell, this agent accumulates within the cytoplasm where it can be imaged using positron emission tomography (PET). Detection of apoptotic cells using this imaging technology may be useful in monitoring tumor responses to cytotoxic therapies. ML-10 appears to mimic the alkyl-malonic acid motif present in gamma -carboxyglutamic (Gla), an amino acid that plays a crucial role in the binding of clotting factors to negatively-charged phospholipids exposed on the surfaces of apoptotic cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Fluorine F 18 ML-10
Foreign brand name:[18F]-ApoSense
Chemical structure name:[18F]-2-(5-fluoro-pentyl)-2-methyl-malonic-acid



Previous:8-hydroxyquinoline sulfate ointment, 851B gel, 852A, 99mTc-DTPA-mannosyl-dextran, [18F]-labeled substance P antagonist receptor quantifier
Next:[F-18]HX4, abagovomab, abarelix, Abegrin, Abelcet

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov